 Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 4 | 1 | 5 | | 2002 | 3 | 1 | 4 | | 2003 | 9 | 0 | 9 | | 2004 | 9 | 2 | 11 | | 2005 | 6 | 3 | 9 | | 2006 | 7 | 4 | 11 | | 2007 | 6 | 2 | 8 | | 2008 | 4 | 1 | 5 | | 2009 | 7 | 5 | 12 | | 2010 | 4 | 2 | 6 | | 2011 | 7 | 3 | 10 | | 2012 | 9 | 6 | 15 | | 2013 | 3 | 3 | 6 | | 2014 | 9 | 2 | 11 | | 2015 | 11 | 1 | 12 | | 2016 | 14 | 4 | 18 | | 2017 | 11 | 3 | 14 | | 2018 | 3 | 2 | 5 | | 2019 | 10 | 1 | 11 | | 2020 | 5 | 3 | 8 | | 2021 | 10 | 1 | 11 | | 2022 | 4 | 0 | 4 | | 2023 | 13 | 0 | 13 | | 2024 | 8 | 1 | 9 | | 2025 | 4 | 3 | 7 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Sordello S, Brock L, Tagliavini A, Federico D, Boulenc X, Pergher M, Huc Claustre E, Metcalf D, Walter ND, Robertson GT, Clary J, Berg A, Mdluli K, Hermann D, Flood D, Upton AM. A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model. Antimicrob Agents Chemother. 2026 Feb 04; 70(2):e0110925.
-
Goletti D, Banaei N, Batra R, Berger AE, Blazevic A, Botelho-Nevers E, Breen R, Bruiners N, Cambau E, Carbonnelle E, Daley CL, Descotes-Genon C, Gennaro FD, Doucet-Populaire F, Esmail A, Guzman JDE, Fontana L, Gennaro ML, Handler D, Torres RMH, Hoft D, Ismail N, Isnard M, Kenny J, Lardizabal A, Lesage FX, Lopes A, Vidal WLL, Contreras RM, Manivet P, Marotte H, Méchaï F, Medjahed-Artebasse A, Meldau R, Mérieux Y, Morel J, Mougari F, Oelofse S, Palmieri F, Perrot JL, Petruccioli E, Pride DT, Tuaillon E, Upton C, Vanker N, Dheda K. Accuracy of VIDAS? TB-IGRA in TB patients and individuals with different thresholds of exposure. Int J Infect Dis. 2026 Mar; 164:108318.
-
Puffal J, Sparks IL, Brenner JR, Li X, Leszyk JD, Hayashi JM, Shaffer SA, Morita YS. Compartmentalized cell envelope biosynthesis in Mycobacterium tuberculosis. mBio. 2026 Jan 14; 17(1):e0268025.
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Hendrix J, Voskuil MI, Obregón-Henao A, Lyons MA, Robertson GT, Moore CM, Walter ND. Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. Antimicrob Agents Chemother. 2025 Nov 05; 69(11):e0049225.
-
Maserumule C, Passemar C, Oh OSH, Hegyi K, Brown K, Weimann A, Dinan A, Davila S, Klapholz C, Bryant J, Verma D, Gadwa J, Krishnananthasivam S, Vongtongsalee K, Kendall E, Trelles A, Hibberd ML, Sanz J, Bertol J, Vázquez-Iniesta L, Andi K, Kumar SS, Ordway D, Prados-Rosales R, MacAry PA, Floto RA. Phagosomal RNA sensing through TLR8 controls susceptibility to tuberculosis. Cell Rep. 2025 May 27; 44(5):115657.
-
Krausser L, Van Dyck-Lippens M, Balde R, Reenaers R, Al Mubarak R, Rigouts L, Walter ND, Voskuil MI, Van Rie A, de Jong BC, Braet SM. 70% ethanol preserves mycobacterial RNA from cultures more efficiently than GTC-TCEP. Sci Rep. 2025 Apr 10; 15(1):12322.
-
Singh M, Sarhan MO, Damiba NNL, Singh AK, Villabona-Rueda A, Nino-Meza OJ, Chen X, Masias-Leon Y, Ruiz-Gonzalez CE, Ordonez AA, D'Alessio FR, Aboagye EO, Carroll LS, Jain SK. Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis. Nat Commun. 2025 Mar 27; 16(1):3003.
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Ektnitphong V, Bauman AA, Massoudi LM, Voskuil MI, Robertson GT, Moore CM, Walter ND. Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0131024.
-
Saukkonen JJ, Duarte R, Munsiff SS, Winston CA, Mammen MJ, Abubakar I, Acuña-Villaorduña C, Barry PM, Bastos ML, Carr W, Chami H, Chen LL, Chorba T, Daley CL, Garcia-Prats AJ, Holland K, Konstantinidis I, Lipman M, Battista Migliori G, Parvez FM, Shapiro AE, Sotgiu G, Starke JR, Starks AM, Thakore S, Wang SH, Wortham JM, Nahid P. Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Jan; 211(1):15-33.
-
Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE, Dartois V, Naidoo T, Steyn AJC, Coler RN, Chan ED. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol. 2024; 15:1427559.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|